Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Classement en actions #41
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Prix de l'action
$459.10
Dernière synchronisation: 2026-09-11
Capitalisation boursière
$359.91B
Changement (1 jour)
0.11%
Changement (1 an)
30.72%
Pays
CH
Échange Roche Holding AG (RO)

Catégorie

Revenus pour Roche Holding AG (RO)
Revenus en Dec 2025 TTM : $77.52B
Selon les derniers rapports financiers de Roche Holding AG, le chiffre d'affaires actuel de l'entreprise (TTM) est de $77.52B. En 2024, l'entreprise a réalisé un chiffre d'affaires de $69.07B une diminution par rapport à le chiffre d'affaires de l'année 2023, qui était de $71.87B. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Roche Holding AG de 2000 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
2026 (TTM) $77.52B 0.00%
2025 $77.52B 12.23%
2024 $69.07B -3.89%
2023 $71.87B 0.96%
2022 $71.19B 3.34%
2021 $68.88B 6.09%
2020 $64.93B -1.48%
2019 $65.90B 8.96%
2018 $60.48B 5.74%
2017 $57.20B 10.60%
2016 $51.72B 2.56%
2015 $50.42B 0.45%
2014 $50.20B -7.86%
2013 $54.48B 9.59%
2012 $49.71B 9.80%
2011 $45.28B -10.87%
2010 $50.80B 7.01%
2009 $47.47B 11.15%
2008 $42.71B 4.63%
2007 $40.82B 18.37%
2006 $34.48B 27.80%
2005 $26.98B -1.91%
2004 $27.51B 8.99%
2003 $25.24B 17.44%
2002 $21.49B 22.59%
2001 $17.53B -0.62%
2000 $17.64B 0.00%
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
$79.67B 2.77%
US
$97.93B 26.33%
US
$64.39B -16.94%
US
$66.40B -14.34%
US
$56.26B -27.43%
CH